Cost-Effectiveness of Primary Implanted Cardioverter Defibrillator for Sudden Death Prevention in Congestive Heart Failure

被引：0
|
作者：
Lei Chen
Joel W. Hay
机构：
[1] University of Southern California,Department of Pharmaceutical Economics and Policy
来源：
Cardiovascular Drugs and Therapy | 2004年 / 18卷
关键词：
Sudden Death; Congestive Heart Failure Patient; Primary Implant; Standard Drug Therapy; Congestive Heart Failure Treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: Implanted cardioverter defibrillator (ICD) is expensive but highly effective in preventing sudden death. The value of primary prophylactic ICD in preventing sudden death for congestive heart failure patients (CHF) has not been established.
引用
收藏
页码：161 / 170
页数：9
相关论文
共 50 条
  • [21] Cost-effectiveness of implantable cardioverter defibrillator therapy
    Morgan, JM
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2002, 13 (01) : S114 - S117
  • [22] Cost-Effectiveness of the Implantable Cardioverter Defibrillator in the Elderly
    Sanders, Gillian O.
    Kong, Melissa
    Al-Khatib, Sana M.
    Peterson, Eric D.
    CIRCULATION, 2008, 118 (18) : S1118 - S1118
  • [23] Patient barriers to implantable cardioverter defibrillator implantation for the primary prevention of sudden cardiac death in patients with heart failure and reduced ejection fraction
    Chan, Laura Lihua
    Lim, Choon Pin
    Aung, Soe Tin
    Quetua, Paul
    Ho, Kah Leng
    Chong, Daniel
    Teo, Wee Siong
    Sim, David
    Ching, Chi Keong
    SINGAPORE MEDICAL JOURNAL, 2016, 57 (04) : 182 - 187
  • [24] Cost-Effectiveness of Primary Prevention Implantable Cardioverter Defibrillator Treatment: Data from a Large Clinical Registry
    Thijssen, Joep
    van Marle, M. Elske van den Akker
    Borleffs, C. Jan Willem
    van Rees, Johannes B.
    de Bie, Mihaly K.
    van der Velde, Enno T.
    van Erven, Lieselot
    Schalij, Martin J.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2014, 37 (01): : 25 - 34
  • [25] The effectiveness of implantable cardioverter-defibrillator in preventing sudden cardiac death in patients with chronic heart failure.
    Eskarayev, T. Talgat
    Iskakova, B. K.
    Moldabeckov, T. K.
    Ainamkulov, S. K.
    Abdulchakov, A. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 378 - 379
  • [26] Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy
    You, John J.
    Woo, Anna
    Ko, Dennis T.
    Cameron, Douglas A.
    Mihailovic, Alexandra
    Krahn, Murray
    AMERICAN HEART JOURNAL, 2007, 154 (05) : 899 - 907
  • [27] Primary hyperparathyroidism and arrhythmic storm in a patient with an implantable cardioverter defibrillator for primary prevention of sudden death
    Occhetta, E
    Bortnik, M
    Magnani, A
    Francalacci, G
    Vassanelli, C
    EUROPACE, 2004, 6 (03): : 184 - 188
  • [28] Cardioverter defibrillators in primary prevention of sudden cardiac death: A cost or an investment?
    Boriani, Giuseppe
    VALUE IN HEALTH, 2007, 10 (01) : 1 - 2
  • [29] Implantable cardioverter defibrillator - powerful weapon in primary and secondary prevention of sudden cardiac death
    Kostic, Tomislav
    Stanojevic, Dragana
    Gudelj, Ognjen
    Milic, Dragan
    Putnik, Svetozar
    Perisic, Zoran
    Djindjic, Boris
    Pavlovic, Milan
    Koracevic, Goran
    Golubovic, Mladjan
    Mitov, Vladimir
    Momcilovic, Stefan
    Bankovic, Sanja
    VOJNOSANITETSKI PREGLED, 2019, 76 (10) : 1007 - 1013
  • [30] Implantable Cardioverter Defibrillator for the Primary Prevention of Sudden Cardiac Death among Patients With Cancer
    Zadok, Osnat Itzhaki Ben
    Agmon, Inbar Nardi
    Neiman, Victoria
    Eisen, Alon
    Golovchiner, Gregory
    Bental, Tamir
    Schamroth-Pravda, Nili
    Kadmon, Ehud
    Goldenberg, Gustavo Ruben
    Erez, Aharon
    Kornowski, Ran
    Barsheshet, Alon
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 191 : 32 - 38
12345